As the coronavirus pandemic grows, so does the reliance on health care workers around the world. From social media salutes to neighborhood parades, the world is finding innovative ways to applaud the efforts of the medical community on the front line of the fight against COVID-19. Read More
As scientists around the world scramble against the COVID-19 clock, searching for a vaccine that could stop the viral infection before it happens, a trio of experts on the University of Colorado Anschutz Medical Campus have taken a different tack: overpowering the new mutation after it invades the body. Read More
It wasn’t long after John Carpenter and Ted Randolph started working at the University of Colorado that a mutual friend and colleague suggested they collaborate. Read More
For some, the word hypnosis can conjure up images of a stage performer dangling a watch in front of a participant’s face. But for many healthcare clinicians, the reality is far removed from that myth: clinical hypnosis is a tool that helps take patients to a deeper state of mind to change behaviors, assist in therapy and help make lasting health changes. Read More
Video courtesy of Stephanie Carlson, Digital Media Manager, 9Health
For patients with a severe form of epilepsy, it can be dangerous to drive, go to work or even walk to the mailbox alone. A fear of falling and blacking out prevents many patients with medically refractory epilepsy from living lives most people take for granted.
“They can’t have a job, they can’t really live a normal life,” said Tom Anchordoquy, PhD, professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. “These patients, before, had to always have someone with them because there was a fear of seizures.”
On top of that, the drugs patients with the severe form of epilepsy take to manage their disorder — which are needed in high concentrations in the brain — are typically taken orally and then distributed throughout the entire body, resulting in problematic side effects. Read More
When Dr. Sunny Linnebur was still a student, she never dreamed the rest of her career would focus on geriatric care.
“It was kind of a surprise to me,” said Linnebur, a professor in the Department of Clinical Pharmacy at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. “And it was because I really lacked exposure to the older adult patient population.”
Now, with a well-established career in the field, she has a 6,000-member platform to use to help spread awareness about geriatrics — and help healthcare professionals of several disciplines find a professional home within the field. Read More
Denver made history this month by effectively decriminalizing psychedelic mushrooms — and experts at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences say the vote marks an important development for the drug, but only time will tell of its impact in a clinical setting.
The initiative, which passed by a close margin and was certified by the city of Denver on May 16, means that arresting anyone for personal possession, consumption or growth of “magic mushrooms” is a low priority for law enforcement. It also prohibits Denver from using city funds to prosecute similar cases.
Hallucinogenic mushrooms haven’t been fully legalized — and unlike marijuana, people won’t be able to legally buy and sell them in the city. Read More
Dr. Richard Radcliffe has always thought of himself as an avid bicyclist, but he never considered signing up for a sponsored bike race.
Not until his daughter, Julie, was diagnosed with Type 1 diabetes at age 13.
Radcliffe, a professor of pharmacology at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences, said shortly after his daughter’s diagnosis, a friend encouraged him to sign up for the American Diabetes Association’s Tour de Cure bike ride, which puts money toward researching treatments — and finding a cure — for diabetes.
The University of Colorado Center for Pharmaceutical Value (PValue) has been established with a Value Assessment Center of Excellence Award from the PhRMA Foundation.
The foundation grant of $500,000 was awarded to Jonathan Campbell, PhD, R. Brett McQueen, PhD, and Melanie Whittington, PhD, who have primary faculty appointments in the field of Pharmaceutical Outcomes Research with the Skaggs School of Pharmacy and Pharmaceutical Sciences on the Anschutz Medical Campus.
PValue will be a center of excellence within the D2V initiative, a Transformational Research Funding project supported by the Dean’s Office of the University of Colorado School of Medicine. D2V will support PValue through a matching award of $500,000. Additional D2V support will include peer review, shared professional research assistance, project management expertise, and institutional accountability. The total award will be allocated over three years to establish PValue initiatives. Read More
When typing the term sabbatical into Google, out spits the following, “a period of paid leave granted to a university teacher or other worker for study or travel, traditionally one year for every seven years worked.” Toggling to Wikipedia yields, “In recent times, “sabbatical” has come to mean any extended absence in the career of an individual in order to achieve something. In the modern sense, one takes sabbatical typically to fulfill some goal, e.g., writing a book or traveling extensively for research.” University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences faculty member Jon Campbell, PhD, recently got to take a sabbatical and chose to go to Hungary. Read More